145 related articles for article (PubMed ID: 15497462)
1. Genetic and immunological analyses of patients with increased serum butyrylcholinesterase activity and its C5 variant form.
Akizuki S; Ohnishi A; Kotani K; Sudo K
Clin Chem Lab Med; 2004; 42(9):991-6. PubMed ID: 15497462
[TBL] [Abstract][Full Text] [Related]
2. The C5 Variant of the Butyrylcholinesterase Tetramer Includes a Noncovalently Bound 60 kDa Lamellipodin Fragment.
Schopfer LM; Delacour H; Masson P; Leroy J; Krejci E; Lockridge O
Molecules; 2017 Jun; 22(7):. PubMed ID: 28661448
[TBL] [Abstract][Full Text] [Related]
3. Butyrylcholinesterase: K variant, plasma activity, molecular forms and rivastigmine treatment in Alzheimer's disease in a Southern Brazilian population.
Bono GF; Simão-Silva DP; Batistela MS; Josviak ND; Dias PF; Nascimento GA; Souza RL; Piovezan MR; Souza RK; Furtado-Alle L
Neurochem Int; 2015 Feb; 81():57-62. PubMed ID: 25624079
[TBL] [Abstract][Full Text] [Related]
4. Butyrylcholinesterase and obesity in individuals with the CHE2 C5+ and CHE2 C5- phenotypes.
Alcântara VM; Oliveira LC; Réa RR; Suplicy HL; Chautard-Freire-Maia EA
Int J Obes Relat Metab Disord; 2003 Dec; 27(12):1557-64. PubMed ID: 14634689
[TBL] [Abstract][Full Text] [Related]
5. Butyrylcholinesterase and C5+ variant in a Javanese ethnic group in Indonesia.
Suyatna FD; Setiabudy R; Herwana E; Tjandra
Int J Clin Pharmacol Ther; 2000 Jul; 38(7):339-44. PubMed ID: 10919342
[TBL] [Abstract][Full Text] [Related]
6. "Warning card" as a prevention of prolonged apnea in children.
Lajtman Z; Surina B; Bartolek D; Car D; Gasparović S; Kirincić N; Rudez J
Coll Antropol; 2002 Dec; 26 Suppl():129-37. PubMed ID: 12674844
[TBL] [Abstract][Full Text] [Related]
7. Association between RAPH1 Gene Haplotypes and CHE2 Locus Phenotypes.
A De Andrade F; Batistela MS; Amaral Sda C; Dos Santos W; Mikami LR; Chautard-Freire-Maia EA; Furtado-Alle L; Souza RL
Ann Hum Genet; 2016 Jul; 80(4):203-9. PubMed ID: 27346732
[TBL] [Abstract][Full Text] [Related]
8. Association of the CHE2 locus with body mass index and butyrylcholinesterase activity.
Alcântara VM; Rodrigues LC; Oliveira LC; Chautard-Freire-Maia EA
Hum Biol; 2001 Aug; 73(4):587-95. PubMed ID: 11512685
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase and diabetes mellitus in the CHE2 C5- and CHE2 C5+ phenotypes.
Cwiertnia MM; Alcântara VM; Réa RR; Faria AC; Picheth G; Scartezini M; Graef LE; Welter M
Arq Bras Endocrinol Metabol; 2010 Feb; 54(1):60-7. PubMed ID: 20414550
[TBL] [Abstract][Full Text] [Related]
10. Butyrylcholinesterase variants (BCHE and CHE2 Loci) associated with erythrocyte acetylcholinesterase inhibition in farmers exposed to pesticides.
Fontoura-da-Silva SE; Chautard-Freire-Maia EA
Hum Hered; 1996; 46(3):142-7. PubMed ID: 8860008
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India.
Manoharan I; Wieseler S; Layer PG; Lockridge O; Boopathy R
Pharmacogenet Genomics; 2006 Jul; 16(7):461-8. PubMed ID: 16788378
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase polymorphisms (BCHE and CHE2 loci) in Brazilian Indian and admixed populations.
Alcântara VM; De Lourenço MA; Salzano FM; Petzl-Erler ML; Coimbra CE; Santos RV; Chautard-Freire-Maia EA
Hum Biol; 1995 Oct; 67(5):717-26. PubMed ID: 8543286
[TBL] [Abstract][Full Text] [Related]
13. DNA mutations associated with the human butyrylcholinesterase J-variant.
Bartels CF; James K; La Du BN
Am J Hum Genet; 1992 May; 50(5):1104-14. PubMed ID: 1349196
[TBL] [Abstract][Full Text] [Related]
14. Evidence for a single butyrylcholinesterase gene in individuals carrying the C5 plasma cholinesterase variant (CHE2).
Masson P; Chatonnet A; Lockridge O
FEBS Lett; 1990 Mar; 262(1):115-8. PubMed ID: 2318303
[TBL] [Abstract][Full Text] [Related]
15. Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.
Bretlau C; Sørensen MK; Vedersoe AL; Rasmussen LS; Gätke MR
Anesth Analg; 2013 Mar; 116(3):596-601. PubMed ID: 23400986
[TBL] [Abstract][Full Text] [Related]
16. No association between butyrylcholinesterase K-variant and Alzheimer disease in Chinese.
Lee DW; Liu HC; Liu TY; Chi CW; Hong CJ
Am J Med Genet; 2000 Apr; 96(2):167-9. PubMed ID: 10893490
[TBL] [Abstract][Full Text] [Related]
17. Concordance of butyrylcholinesterase phenotype with genotype: implications for biochemical reporting.
Parnas ML; Procter M; Schwarz MA; Mao R; Grenache DG
Am J Clin Pathol; 2011 Feb; 135(2):271-6. PubMed ID: 21228368
[TBL] [Abstract][Full Text] [Related]
18. Effects of energetic restriction diet on butyrylcholinesterase in obese women from southern Brazil - A longitudinal study.
Santos WD; Tureck LV; Saliba LF; Schenknecht CS; Scaraboto D; Souza RLR; Furtado-Alle L
Arch Endocrinol Metab; 2017; 61(5):484-489. PubMed ID: 28658346
[TBL] [Abstract][Full Text] [Related]
19. Haplotypes of butyrylcholinesterase K-variant and their influence on the enzyme activity.
Jasiecki J; Żuk M; Krawczyńska N; Jońca J; Szczoczarz A; Lewandowski K; Waleron K; Wasąg B
Chem Biol Interact; 2019 Jul; 307():154-157. PubMed ID: 31071335
[TBL] [Abstract][Full Text] [Related]
20. Acetylcholine-metabolizing butyrylcholinesterase (BCHE) copy number and single nucleotide polymorphisms and their role in attention-deficit/hyperactivity syndrome.
Jacob CP; Weber H; Retz W; Kittel-Schneider S; Heupel J; Renner T; Lesch KP; Reif A
J Psychiatr Res; 2013 Dec; 47(12):1902-8. PubMed ID: 24041656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]